https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-25 / Pancreatology 2008;8(4-5):431-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-25 / Pancreatology 2008;8(4-5):431-612008-08-25 00:00:002019-02-15 09:23:41Biological approaches to therapy of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-22 / Cancer Immunol. Immunother. 2009 Jan;58(1):1-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-22 / Cancer Immunol. Immunother. 2009 Jan;58(1):1-142008-08-22 00:00:002019-02-15 09:19:19Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-19 / Mol. Ther. 2008 Nov;16(11):1883-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-19 / Mol. Ther. 2008 Nov;16(11):1883-902008-08-19 00:00:002019-02-15 09:21:57Recombinant Newcastle disease virus as a vaccine vector for cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-242008-08-12 00:00:002019-02-15 08:52:02Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Clin. Cancer Res. 2008 Aug;14(15):4850-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Clin. Cancer Res. 2008 Aug;14(15):4850-82008-08-01 00:00:002008-08-01 00:00:00A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / J Biomech Eng 2008 Aug;130(4):0410162008-08-01 00:00:002019-02-15 10:00:35A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-4082008-08-01 00:00:002008-08-01 00:00:00Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-502008-08-01 00:00:002019-02-15 08:49:31Dendritic cell vaccines in metastasized malignant melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-92008-08-01 00:00:002019-02-15 09:22:02Oncolytic virotherapy as a personalized cancer vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Curr. Opin. Mol. Ther. 2008 Aug;10(4):371-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Curr. Opin. Mol. Ther. 2008 Aug;10(4):371-92008-08-01 00:00:002019-02-15 09:21:59Virus combinations and chemotherapy for the treatment of human cancers
